Inotuzumab Ozogamicin

Inotuzumab Ozogamicin · Targeted Antibody-Drug Conjugate (ADC)

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL) or CD33-positive Acute Myeloid Leukemia (AML).

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Hepatotoxicity, hepatic veno-occlusive disease (sinusoidal obstruction syndrome), myelosuppression.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.